http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050053613-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a4b478b2de0b6e2003167732f7d4a7b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147 |
| filingDate | 2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38fe38799a03e68035502f6335b49c66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_307afd9b117358be718b7327c3e16398 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e3684cc289fa780a4d40bcd65b1ae37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebb2b59740fd6418a44313a28ba6c1fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ca748238ee960ec410727600b6931ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85bb939ca46b014b71864a3dc5668568 |
| publicationDate | 2005-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20050053613-A |
| titleOfInvention | Antitumoral analogs of lamellarins |
| abstract | The present invention provides a novel lamellarin of formula III; Or to pharmaceutically acceptable salts, derivatives, prodrugs or stereoisomers thereof:n n n Formula IIIn n n n n n n n Wheren n n X is selected from the group consisting of N, O and S;n n n R 1 , R 2 , R 3 . R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently H, OH, OR ', SH, SR', SO 2 R ', NHR', N (R ') 2 , N = R ', NHCOR', N (COR ') 2 , NHSO 2 R', NO 2 , PO (R ') 2 , PO 2 R', C (= O) H, C (= O) R ', CO 2 H, CO 2 R ', NHSO (R') 2 , OPO 2 R ', OC (= 0) H, OC (= 0) R', N = C (R ') 2 , substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted aryl , Substituted or unsubstituted aralkyl and substituted or unsubstituted hetero aromatic;n n n Each R ′ is independently H, OH, NO 2 , NH 2 , SH, CN, halogen, ═O, C (═O) H, C (═O) CH 3 , CO 2 H, C (═O) R ', Substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted Substituted C 1 -C 18 alkoxyl, substituted or unsubstituted C 1 -C 18 aminoalkyl, substituted or unsubstituted C 1 -C 18 amino acid, substituted or unsubstituted C 1 -C 18 thioalkyl, substituted or unsubstituted C 1 -C 18 alkylsulfinyl and substituted or is selected from the group consisting of unsubstituted C 1 -C 18 alkylsulfonyl;n n n R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 3 and R 9 , R 4 and R 9 , R 9 and R 5 , R 9 and R 6 , R 6 and R 7 or pairs of R 7 and R 8 may be bonded into a carbocyclic or heterocyclic ring system;n n n Dotted lines represent single or double bonds. |
| priorityDate | 2002-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 232.